Skip to main content

Find Clinical Trials

Home
Conditions
Blasts 20-30 Percent of Peripheral Blood White Cells

Clinical trial condition

Blasts 20-30 Percent of Peripheral Blood White Cells

Explore clinical trials studying Blasts 20-30 Percent of Peripheral Blood White Cells. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Blasts 20-30 Percent of Peripheral Blood White Cells trial results

Completed

Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome

NCT03047993

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of Peripheral Blood White Cells, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details